|
![]() |
|||
|
||||
OverviewClinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials. Table of Contents Front Matter 1 Introduction 2 Framing the Problem 3 Recruitment Challenges in Clinical Trials for Different Diseases and Conditions 4 Models for Public Engagement 5 Messages and Methods for Public Engagement 6 The Media 7 Novel Clinical Trial Designs 8 The Health System's Structure and Culture 9 Toward a Patient-Centered Strategy for Clinical Trials References Appendix A: Workshop Agenda Appendix B: The Clinical Trials Process Appendix C: Participant Biographies Full Product DetailsAuthor: Institute of Medicine , Board on Health Sciences Policy , Forum on Drug Discovery, Development, and Translation , Anne B. ClaibornePublisher: National Academies Press Imprint: National Academies Press ISBN: 9780309219297ISBN 10: 0309219299 Pages: 140 Publication Date: 17 March 2012 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1 Front Matter; 2 1 Introduction; 3 2 Framing the Problem; 4 3 Recruitment Challenges in Clinical Trials for Different Diseases and Conditions; 5 4 Models for Public Engagement; 6 5 Messages and Methods for Public Engagement; 7 6 The Media; 8 7 Novel Clinical Trial Designs; 9 8 The Health System's Structure and Culture; 10 9 Toward a Patient-Centered Strategy for Clinical Trials; 11 References; 12 Appendix A: Workshop Agenda; 13 Appendix B: The Clinical Trials Process; 14 Appendix C: Participant BiographiesReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |